HomeCompareSSMXY vs GBDC

SSMXY vs GBDC: Dividend Comparison 2026

SSMXY yields 1.20% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.75M in total portfolio value
10 years
SSMXY
SSMXY
● Live price
1.20%
Share price
$8.69
Annual div
$0.10
5Y div CAGR
20.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$975.85
Full SSMXY calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — SSMXY vs GBDC

📍 GBDC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSSMXYGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SSMXY + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SSMXY pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SSMXY
Annual income on $10K today (after 15% tax)
$102.07/yr
After 10yr DRIP, annual income (after tax)
$829.47/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $13,930,044.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SSMXY + GBDC for your $10,000?

SSMXY: 50%GBDC: 50%
100% GBDC50/50100% SSMXY
Portfolio after 10yr
$10.40M
Annual income
$8,195,119.63/yr
Blended yield
78.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

SSMXY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
5.0
Piotroski
6/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SSMXY buys
0
GBDC buys
0
No recent congressional trades found for SSMXY or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSSMXYGBDC
Forward yield1.20%11.85%
Annual dividend / share$0.10$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR20.8%51.1%
Portfolio after 10y$25.1K$20.78M
Annual income after 10y$975.85$16,389,263.41
Total dividends collected$4.4K$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: SSMXY vs GBDC ($10,000, DRIP)

YearSSMXY PortfolioSSMXY Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$10,845$145.06$12,490$1,790.28$1.6KGBDC
2$11,782$177.60$16,522$3,157.73$4.7KGBDC
3$12,824$217.83$23,578$5,898.68$10.8KGBDC
4$13,990$267.69$37,115$11,886.75$23.1KGBDC
5$15,299$329.67$66,136$26,423.57$50.8KGBDC
6$16,777$407.02$137,257$66,491.44$120.5KGBDC
7$18,455$503.90$341,734$194,868.54$323.3KGBDC
8$20,373$625.80$1,050,788$685,133.02$1.03MGBDC
9$22,579$779.92$4,099,314$2,974,971.01$4.08MGBDC
10$25,135$975.85$20,775,530$16,389,263.41$20.75MGBDC

SSMXY vs GBDC: Complete Analysis 2026

SSMXYStock

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Full SSMXY Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this SSMXY vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SSMXY vs SCHDSSMXY vs JEPISSMXY vs OSSMXY vs KOSSMXY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.